Vietnam says Pfizer and MSD to grant its firms licenses to produce Covid-19 pills


South Korean tourists arrive at a hotel in Phu Quoc island, among the first wave of visitors in nearly two years as the country seeks to resurrect its pandemic-ravaged tourism economy, in Vietnam, November 20, 2021. - Reuters

HANOI, Nov 26 (Reuters): Drugmakers Pfizer Inc and MSD, known as Merck & Co Inc in North America, have agreed to give licenses to firms in Vietnam to produce Covid-19 treatment pills, Vietnam's ministry of health said on Friday.

The companies have sent letters of approval to the Drug Administration of Vietnam, the ministry said in a statement, for the production of Molnupiravir and Paxlovid pills.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Vietnam , Pfizer , MSD

Next In Aseanplus News

Businessman claims trial to assaulting foreign woman at KL club
Malaysia, Pakistan share diplomatic experiences in resolving conflicts
Seven areas in Malaysia record unhealthy API readings as of 9am
Govt under fire over Imran’s care
Experts: EPF still on track to deliver 6% dividend
M’sia calls for greater Asean vigilance over haze threat
Cops probe bullying link in female student’s death
Govt drops Netflix show deal after outcry
No ‘good’ air recorded
Dad ditches seven-year-old son to climb Mount Fuji

Others Also Read